ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
NCT05122039 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-07-01
Summary
The main purpose of the PICASSO-project is to facilitate future psoriasis-research in dermatology. This register biobank will enable us to perform research in the field of metabolomics, mRNA-expression, cardiovascular impact and the microbiome. The final aims are patient stratification, better insight in disease-evolution and improved understanding of markers that predispose to severe disease.
Conditions
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Tom Hillary, MD · Department of Dermatology, University Hospitals Leuven
Eligibility
- Min Age
- 12 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-20
- Primary Completion
- 2032-10-19
- Completion
- 2032-10-19
Countries
- Belgium
Study Locations
More Related Trials
-
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
NCT07298265 ·Status: RECRUITING
-
Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis
NCT03475914 ·Status: COMPLETED
-
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
NCT04099979 ·Status: WITHDRAWN
-
LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
NCT02888236 ·Status: COMPLETED ·Phase: PHASE2
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis
NCT04513847 ·Status: COMPLETED
-
Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis
NCT02162472 ·Status: COMPLETED
-
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
NCT00050648 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
NCT05144165 ·Status: UNKNOWN
-
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
NCT02274363 ·Status: COMPLETED
-
Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)
NCT06905028 ·Status: RECRUITING ·Phase: NA
-
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
NCT00617994 ·Status: COMPLETED ·Phase: PHASE2
-
Body PSOriasis: Long-term Relapse CONTROL
NCT03402828 ·Status: COMPLETED
-
PsoBest - The German Psoriasis Registry
NCT01848028 ·Status: RECRUITING
-
Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current
NCT01765985 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Deucravacitinib to Treat LPP and FFA
NCT06091956 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
Serum Granulysin Level as a Marker to Detect the Severity of Psoriasis
NCT03469219 ·Status: UNKNOWN
-
A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions
NCT02626793 ·Status: COMPLETED
-
A Study of DLX105-DMP in Subjects With Plaque Psoriasis
NCT04203433 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Education Program in Psoriasis
NCT02310204 ·Status: COMPLETED ·Phase: NA
-
Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
NCT01595997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study
NCT01702324 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
NCT03791216 ·Status: COMPLETED
-
Can We Miss Pigmented Lesions in Psoriasis Patients?
NCT01053819 ·Status: COMPLETED ·Phase: PHASE4